UUID: 7E33F018- -6494- 413F- -A68D- AC-4013916756ac
TCGA- YL- -A859- 0111- -PR Red

III IIIII|IIIIIIIIIIIIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIIIIaIIICIItad
IIII IIIIIII IIIII IIIIIIII IIIIIIIIIIIIIIIIIIIII
III IIIIIII I IIIIIIIII IIIII I I I IIIII II IIIIIII III IIIII I III

PROSTATE AND PELVIC/OBTURATOR QMPH NODE_S: RADICAL PROSTAT§CTOMY2
TUMOR PROCUREMENT: '
HISTOLOGIC TYPE
ACINAR ADENOCARCINOMA
HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATTERN: GLEASON SCORE):
4 + 5: 9
TERTIARY PATTERN 3 5' W 3"“; PW dy ”45 I 7 I

PERCENTAGE OF DIFFERENT GLEASON PATTERNS

NOT REPORTED é " b .3
TUMOR LOCATION I ‘D

APEX

ﬂdeLaV/mmyb ms Mam/3
ANTERIOR

RIGHT < % 7n » 2° ('6 /. 0/
LEFT 04/11. . JAG MS
POSTERIOR
RIGHT
LEFI'
EXTRA-PROSTATIC EXTENSION
PRESENT
FOCAL
SITE OF EXTRA-PROSTATIC EXTENSION
ANTERIOR
LEFT
SEMINAL VESICAL INVASION
ABSENT
SURGICAL MARGINS
INVOLVED BY INVASIVE CARCINOMA
APEX
ANTERIOR
RIGHT
LEFT
NATURE OF POSITIVE MARGINS
NOT REPORTED
EXTENT OF POSITIVE MARGINS
MULTIFOCAL
MILLIMETRIC EXTENT OF POSITIVE MARGINS: _NOT REPORTED

GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS
NOT REPORTED

LYMPHOVASCULAR INVASION
NOT REPORTED
PERINEURAL INVASION
PRESENT
TUMOR VOLUME
PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: _50%
TREATMENT EFFECT ON CARCINOMA
NOT APPLICABLE
LYMPH NODES
LEFT PELVIC
NUMBER OF NODES INDENTIFIED: _2_
NUMBER OF NODES INVOLVED BY METASTASIS: _O__
RIGHT OBTURATOR
NUMBER OF NODES INDENTIFIED: _3_
NUMBER OF NODES INVOLVED BY METASTASIS: _0_

la n/I

Case
Reviewer lmtials Reviewed:

 

PATHOLOGICAL STAGING
pT3a
pNO
pMX

 

 

 

TCGA Pathologic Diagnosis Discrepancy Form

 

 

 

 

 

mm The TCG/l Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted for TCGA is inconsistent with the diagnosis provided on the
Case Quality Control Form completed for the submitted case.

 

 

 

 

 

 

 

Tissue Source Site (1'55): _‘ _TSS Identifier: __ _TSS Unique Patient Identiﬁer:
Completed By (IntewiewerName on OpenCII'nica}: .. _AwCompIeted Date: w
Diagnosis Information
ii Data Element Entry Alternatives Working Instructions
| , . Proyiae the diagnosis] histologic‘subiypeﬁ) dooumentcd on
1 :3;t:;:g*g§;:éggr‘s We 2, . mom/Wm trainsneezing:transits: We

armor/J (Jr 5: 57

Pithl R rt . 4-
1 ° °gy 9‘” mean” £47781le

 

llistologic features of Provxde the histologic features selected on the TCGA Case

 

2 the sample provided ﬂdm’flé -‘7AL%'IWCJNUMQ QuaIIIy comm] Form compIeLw for this case.
for TCGA, as reﬂected (3173339 .5"! S": c?
on the CQCF.

 

 

IDiscrepancy between Pathology Report and Case Quality Control Form

 

 

3 Provide the reason for Provide a reason describingwhy lIIc dingnOSIs on the initial

- . '- _ S I , ~ pathology report for this case is not consistent with the
the discrepancy WW 0‘2} I)“; diagnosis Selected on the TCGA Case Quality Control Form.
between the pathology

reportand theTCGA " ‘ ( \ u t . i.
CaseQualityControl ’S‘VLM'LCQ) '9 aH/‘J'WV/ M77531: :3

Fa rm.

(Win/x1e; fame)

 

Name of 1'35 Reviewing Provide the name of the pathologist who reviewed this case

4 Pathologist or fDrTCGA.
Biorepository Director

 

 

 

 

 

 

I acknowledge that the above information provided by my institution is true and correct and has been qualizy controlled.

 

'I‘SS Reviewing Pathologist or Biorepository Director Date

l acknowledge that the above information provided by my institution is true and correct and has been quality controlled. The Attending Pathologist or the
Department Chairman has been informed or is aware of the above discrepancy in diagnoses.

 

Principal Investigator Signature Date

